ArticleInternational journal of hematology2013

Recombinant human soluble thrombomodulin is active against hemophagocytic lymphohistiocytosis associated with acquired immunodeficiency syndrome.

SungGi Chi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.